All HHS Contracts — September 04, 2026

ATCC's $141M cost-plus-fixed-fee contract to operate the MID BRR for NIH/NIAID (2016-2023) signals a strong competitive moat in biological reference materials, with low profit risk due to cost-plus pricing. The contract's end in Oct 2023 creates a catalyst for a recompete, where ATCC's incumbency is a bullish factor.

ATCC's contract ended Oct 2023 with only $63.5M outlayed (45% of $141M ceiling), and Guidehouse Digital's $130M software support contract ended Sept 2022 with $52.3M outlayed (40% of ceiling). This implies scope reductions, delays, or underperformance, with no current revenue from either award.

Guidehouse Digital's $130M labor-hours delivery order for NIH bioinformatics software support ended in 2022 with only $52.3M outlayed. The contract's expiration and low outlay rate suggest limited ongoing revenue contribution, and no recompete has been identified.

ATCC's MID BRR contract had a large gap between obligated ($141M) and outlayed ($63.5M) funds, indicating possible scope changes, delays, or lower-than-planned spending. This execution risk could affect ATCC's ability to win the follow-on contract.

Both contracts are from NIH (civilian), creating agency concentration risk. Any NIH budget cuts or CR-driven delays could impact future awards to both ATCC and Guidehouse Digital.

ATCC's incumbency in the MID BRR contract positions it favorably for a recompete, given the bipartisan support for NIH/NIAID infectious disease research and biodefense. The cost-plus pricing structure also ensures stable margins.

Guidehouse Digital could benefit from NIH's continued digitization of biomedical research data, as evidenced by its $130M bioinformatics software support contract. A recompete or new task order under the same IDIQ could provide revenue growth.

Both contracts support NIH's mission in infectious disease research and bioinformatics, with ATCC's $141M repository contract and Guidehouse's $130M software support contract. This theme is supported by strong bipartisan funding for NIH/NIAID, though both contracts are expired.

{"entity" => "American Type Culture Collection (ATCC)", "reason" => "Incumbent on $141M MID BRR contract that ended Oct 2023; recompete is a key catalyst for future revenue.", "trigger" => "Recompete announcement or extension of MID BRR contract"}

{"entity" => "Guidehouse Digital LLC", "reason" => "Expired $130M NIH bioinformatics contract (ended Sept 2022); new task orders or recompete could signal revenue recovery.", "trigger" => "NIH recompetition for bioinformatics software support (NAICS 541512)"}